West Asia Conflict Triggers Medical Device Supply Crisis and Price Surge in India
The escalating conflict in West Asia is now sending shockwaves through India's domestic medical device industry, with manufacturers issuing urgent warnings about potential shortages of essential hospital consumables as early as the coming month. This crisis is compounded by a severe shortage of industrial gas used in boilers and skyrocketing energy costs, forcing companies to rely on more expensive alternatives like diesel or power backups. Industry experts have revealed to TOI that most manufacturers maintain barely 15 to 20 days of raw material inventory, meaning the squeeze could rapidly disrupt production and supply of critical disposables to hospitals and healthcare facilities nationwide.
Immediate Threats to Hospital Supplies and Raw Material Costs
Typically, hospitals carry only a couple of days' inventory of disposables, including IV bags and lines, cannulas, syringes, and surgical items. A sharp escalation in the prices of key medical-grade plastics is intensifying pressure on device manufacturers. In March alone, the cost of widely used polymers has surged dramatically: ABS has climbed from about Rs 140 per kg to nearly Rs 190, while SAN has risen from Rs 135 to Rs 180. Polycarbonate has jumped to around Rs 240 per kg, and polypropylene—essential for a large range of disposables—has increased from roughly Rs 103 to Rs 147 per kg.
Other critical inputs, including LDPE, HDPE, and polyester chips, have experienced similar price spikes. PVC compounds and resins, vital for products such as infusion sets and urine bags, have also seen significant increases. Industry executives emphasize that the surge is not merely about higher prices but also tightening availability, with shortages of several grades of medical plastics beginning to emerge.
Industry Leaders Voice Deep Concerns Over Rising Costs
Himanshu Baid, Managing Director of Poly Medicure, expressed grave concerns, stating, "We are deeply worried about the spike in input costs, with prices of key raw materials rising by an average of 30%. Simultaneously, freight costs have nearly doubled due to higher insurance premiums and war-risk surcharges on shipping routes. Coupled with shortages of industrial gas, these factors are significantly increasing production costs and will put immense pressure on operations in the coming months."
The impact could be particularly severe for the sector's vast base of small manufacturers, as nearly 90% of domestic medical device companies are MSMEs. Many of these businesses are already struggling with hoarding of key plastics and volatile input prices, threatening their survival.
Geopolitical Tensions and Calls for Government Intervention
Rajiv Nath, Forum Coordinator of AiMeD, highlighted the broader implications, saying, "The Strait of Hormuz blockade and Middle East tensions have spiked medical device input costs by nearly 50% for plastics and doubled PNG gas prices used for power generation, eroding thin margins on essentials like syringes and catheters. While one to three-week shipment delays are manageable via buffers, prolonged disruptions risk production halts, hospital shortages, and inflated prices from market abuse by dominant large raw materials players. Urgent government action is needed to safeguard over 5 lakh jobs, particularly in the MSME sector."
An executive from Sarjak Container Lines, a shipping and project logistics company, added, "For smaller exporters who operate with limited financial buffers, these disruptions can quickly translate into liquidity stress. Temporary financial support mechanisms could help stabilize MSME exporters during this period of geopolitical uncertainty."
As the West Asia conflict continues to unfold, the Indian medical device industry faces a precarious future, with potential ramifications for healthcare delivery and economic stability. Stakeholders are urging swift policy measures to mitigate the crisis and ensure uninterrupted access to vital medical supplies.
